DNMT3A and myelodysplastic syndrome: In addition, loss-of-function mutations in the DNMT3A gene are one of the most frequent defects identified in acute myeloid leukemia (AML; ~30%) or myelodysplastic syndrome (MDS; 2–10%) patients [30].